Undiagnosed malignancy in patients with deep vein thrombosis: Incidence, risk indicators, and diagnosis

Cancer

Volumn 83, Issue 1, 1998, Pages 180-185

  Hettiarachchi, Rohan J K ^a   Lok, Judith ^a,b   Prins, Martin H ^a   Büller, Harry R ^a   Prandoni, Paolo ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Istituto di Semeiotica Medica II   (Italy)

Author keywords

Cohort analysis; Deep vein thrombosis; Malignancy; Screening for cancer

Indexed keywords

HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK; THROMBOPHLEBITIS;

EID: 0032127377     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<180::AID-CNCR24>3.0.CO;2-S     Document Type: Article

References (15)

1. Trousseau A. Phlegmasia alba dolens. Clinque Medicale de l'Hôtel-Dieu de Paris, 2nd ed., Vol. 3. Paris: JB Bailliere. 1865:659-712.
2. Siegelman ES, Needleman L. Venous thrombosis and cancer [letter]. N Engl J Med 1992;328:885.
3. Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982;96:556-60.
4. Goldberg RJ, Seneff M, Gore JM, Anderson FA, Green HL, Wheeler HB, et al. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987;147: 251-3.
5. Griffin MR, Stanson AS, Brown ML, Hauser MF, O'Fallon WM, Anderson HN, et al. Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasms. Arch Intern Med 1987;147:190-11.
6. Monreal M, Salvador R, Soriano V, Sabria M. Cancer and deep venous thrombosis. Arch Intern Med 1988;148:485.
7. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Ma Callejas J, et al. Occult cancer in patients with venous thrombosis. A systematic approach. Cancer 1991;67:541-5.
8. Prandoni P, Lensing AWA, Buller H, Cogo A, Prins MH, Cattelan AM, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327: 1128-33.
9. Ahmed Z, Mohyuddin Z. Deep vein thrombosis as a predictor of cancer. Angiology 1996;47:261-5.
10. Bastounis EA, Karayiannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med 1996;239:153-6.
11. Ranft J, Heidrick H. Frequency of malignant diseases in deep vein thrombosis of the lower extremity. Int Angiol 1991;10: 66-8.
12. Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994;308:891-4.
13. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med 1996;125:785-93.
14. Prins MH, Lensing AWA, Hirsh J. Idiopathic deep venous thrombosis. Is a search for malignant disease justified? Arch Intern Med 1994;154:1310-2.
15. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, Van der Meer J, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7.